Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy and safety of Botulinum Toxin Type A versus placebo (normal saline) as headache prophylaxis in adolescents (children 12 to 17) with chronic migraine.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT04715685 · Headache, Headache Disorders, and more
NCT07170176 · Migraine Disorders, Patent Foramen Ovale, and more
NCT05570149 · Migraine Disorders
NCT05690737 · Migraine Disorders
NCT06549270 · Migraine Disorders, Chronic Migraine, and more
Phoenix Children's Hospital
Phoenix, Arizona
Fullerton Neurology and Headache Center
Fullerton, California
The Research Center of Southern California
Oceanside, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions